Laman UtamaGRAL • NASDAQ
add
Grail Inc
Tutup sebelumnya
$44.34
Julat hari
$41.53 - $44.95
Julat tahun
$20.44 - $118.84
Permodalan pasaran
1.74B USD
Bilangan Purata
1.73J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 43.60J | 13.97% |
Perbelanjaan pengendalian | 146.75J | 28.76% |
Pendapatan bersih | -99.18J | -2.17% |
Margin untung bersih | -227.48 | 10.35% |
Pendapatan bagi setiap syer | -2.44 | — |
EBITDA | -85.50J | -49.94% |
Kadar cukai berkesan | 14.88% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 904.43J | 18.46% |
Jumlah aset | 2.92B | -2.05% |
Jumlah liabiliti | 344.15J | -28.29% |
Jumlah ekuiti | 2.58B | — |
Syer tertunggak | 41.02J | — |
Harga kepada buku | 0.69 | — |
Pulangan pada aset | -11.26% | — |
Pulangan pada modal | -12.61% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -99.18J | -2.17% |
Tunai daripada operasi | -63.78J | 31.77% |
Tunai daripada pelaburan | -236.70J | 56.66% |
Tunai daripada pembiayaan | 423.32J | — |
Perubahan bersih dalam tunai | 122.84J | 119.20% |
Aliran tunai bebas | -20.80J | -171.95% |
Perihal
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 Galleri launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
Diasaskan
2015
Ibu pejabat
Tapak web
Pekerja
910
